Vaccines - Products

Bacterial Vaccines:

B.C.G. Vaccine; Diphtheria and Tetanus Vaccine Adsorbed (Td Vaccine); Diphtheria, Tetanus, and Pertussis Vaccine Adsorbed (DTP Vaccine); Meningococcal Polysaccharide Vaccine, Groups A & C.

B.C.G. Vaccine, Freeze-Dried (Live) (0.1 mL / dose) - Freeze-dried B.C.G. is a dried preparation containing live bacteria derived from a culture of the Bacillus of Calmette and Guerin, known as B.C.G. For primary immunization of infants and immunization or reimmunization of children and adults who have reacted negatively to the usual tuberculin tests. For the purpose of primary immunization, it is recommended that 1 dose of 0.1 mL of the reconstituted vaccine be given intradermally.

B.C.G. Vaccine, Freeze-Dried (Live) (0.05 mL / dose) - Freeze-dried B.C.G. is a dried preparation containing live bacteria derived from a culture of the Bacillus of Calmette and Guerin, known as B.C.G. The vaccine should be given routinely to all infants at risk of early exposure to the disease. For infants under one year of age, 0.05 mL of the reconstituted vaccine should be given intradermally.

Diphtheria and Tetanus Vaccine Adsorbed (Td Vaccine) (Adult) - For the booster vaccination of adults and older children who have been previously immunized against diphtheria and tetanus. Due to the reduced Diphtheria Toxoid content of this vaccine it is not recommended for primary immunization of children and adults.

Diphtheria and Tetanus Vaccine Adsorbed (DT Vaccine) (Pediatric) - For the primary immunization and re-immunization of children up to 10 years of age and infants above the age of two months in whom pertussis vaccination is contraindicated.

Diphtheria, Tetanus, and Pertussis Vaccine Adsorbed (DTP Vaccine) - For the primary immunization of infants above the age of two months, and for pre-school children against diphtheria, tetanus, and whopping cough.

Tetanus Toxoid Vaccine Adsorbed - For the prevention of tetanus in children and adults, especially those liable to be exposed to tetanus infection, particularly women of child-bearing age and persons engaged in outdoor activities e.g. gardeners, farm workers, and athletes. The vaccine is used in the prevention of neonatal tetanus by immunizing women of child-bearing age and also in the prevention of tetanus following injury.

Meningococcal Polysaccharide Vaccine, Groups A & C, Freeze Dried - For the prevention of meningococcal disease and is indicated for persons:

  • who come in contact with a patient affected by the meningococcal disease (family, school, and professional contacts);
  • who travel to endemic areas (Sub-Sahara region in Africa);
  • who go on pilgrimage to Mecca;
  • who have undergone splenectomy or have a functional spleen disturbance;
  • with immunodeficiences in complement components

The vaccines meet the requirements established by the World Health Organization and European Pharmacopoeia.

Viral Vaccines:

Measles Vaccine Live; Mumps Vaccine Live; Rubella Vaccine Live; Measles and Rubella (MR) Vaccine Live; Measles, Mumps and Rubella (MMR) Vaccine Live

Measles Vaccine Live, Attenuated, Freeze Dried - For active immunization against measles. A single dose of this vaccine can provide prolonged immunity to infection. In countries where the incidence and mortality from measles in the first year of life is high, the recommended age for immunization is as soon after 9 months as possible. Countries where measles are less of a problem may decide to immunize later.

Mumps Vaccine Live, Attenuated, Freeze-Dried - For active immunization against mumps (mumps prophylaxis). The mumps vaccination is indicated in all children 12 months of age or older; for susceptible, non-pregnant adolescent and adult women; for postpartum, non-immunized women; and for non-immunized adults who intend to travel to areas that have a high incidence of mumps.

Rubella Vaccine Live, Attenuated, Freeze-Dried - For active immunization against rubella in children from 1 to 15 years of age. The vaccine is also recommended for use in women of childbearing age, especially those who may be most exposed e.g. working in medical institution, nurseries and schools.

Measles and Rubella (MR) Vaccine Live, Attenuated, Freeze-Dried - For active immunization against measles and rubella in children and infants. Measles, Mumps and Rubella (MMR) Vaccine Live, Attenuated, Freeze-Dried - For active immunization against measles, mumps, and rubella in infants older than 12 months of age, children, and adolescents.

The vaccines meet European pharmacopoeia.

Antitoxins:

Diphtheria Antitoxin (Equine); Snake Venom Antitoxin; Tetanus Antitoxin (Equine)

Diphtheria Antitoxin (Equine) - The preparation is a clear, sterile, apyrogenic solution. Diphtheria Antitoxin (Equine) is the immunoglobulin fraction of the plasma of immunized horses for the prevention and therapy of diphtheria. The preparation is to be injected intramuscularly or subcutaneously.

Tetanus Antitoxin (Equine) - The preparation is a clear, sterile, apyrogenic solution. Tetanus Antitoxin (Equine) is the immunoglobulin fraction of the plasma of immunized horses for the prevention and therapy of tetanus. The preparation is to be injected intramuscularly or subcutaneously.

All Antitoxins meet the requirements established by the World Health Organization.

Plasma:

Normal Serum Albumin; Tetanus Immunoglobulin; Rabies Immunoglobulin; Hepatitis B Immunoglobulin

  • Normal Serum Albumin
  • Tetanus Immunoglobulin
  • Rabies Immunoglobulin
  • Hepatitis B Immunoglobulin

Diagnostics

Purified Protein Derivative of Tuberculin (PPD) for Intradermal Tests (Mantoux)

Purified Protein Derivative of Tuberculin (PPD) for Intradermal Tests (Mantoux) - The preparation represents dry purified protein derivative of tuberculin that has been dissolved in isotonic phosphate buffer. Stabilized Standard PPD Solutions are intended for Mantoux's intradermal test for:

  • diagnosis and differential diagnosis of tuberculosis;
  • early detection of tuberculosis in children;
  • screening for infection by M. tuberculosis or atypical mycobacteria;
  • examination for allergy acquired after BCG vaccination;
  • identification of subjects for BCG revaccination.

This product meets the requirements established by the World Health Organization